美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件:" 药品名称=MILNACIPRAN HYDROCHLORIDE"
商品名 申请号 产品号 申请类型 活性成分 剂型/给药途径 规格/剂量 RLD RS 申请号原始批准/暂定批准日期 产品号批准日期 申请人 市场状态
LEVOMILNACIPRAN HYDROCHLORIDE 210790 002 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 40MG BASE No No 2019/02/04 2019/02/04 AMNEAL PHARMS CO Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210790 003 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 80MG BASE No No 2019/02/04 2019/02/04 AMNEAL PHARMS CO Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210790 004 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 120MG BASE No No 2019/02/04 2019/02/04 AMNEAL PHARMS CO Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210732 001 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 20MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210732 002 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 40MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210732 003 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 80MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210732 004 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 120MG BASE No No 2020/11/05 2020/11/05 HIKMA Discontinued
MILNACIPRAN HYDROCHLORIDE 205367 001 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 12.5MG No No 2020/12/28 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 205367 002 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 25MG No No 2020/12/28 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 205367 003 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 50MG No No 2020/12/28 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 205367 004 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 100MG No No 2020/12/28 (TA) -- MYLAN PHARMS INC None (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 210944 001 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 12.5MG No No 2022/01/05 (TA) -- MACLEODS PHARMS LTD None (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 210944 002 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 25MG No No 2022/01/05 (TA) -- MACLEODS PHARMS LTD None (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 210944 003 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 50MG No No 2022/01/05 (TA) -- MACLEODS PHARMS LTD None (Tentative Approval)
MILNACIPRAN HYDROCHLORIDE 210944 004 ANDA MILNACIPRAN HYDROCHLORIDE TABLET;ORAL 100MG No No 2022/01/05 (TA) -- MACLEODS PHARMS LTD None (Tentative Approval)
LEVOMILNACIPRAN HYDROCHLORIDE 210826 001 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 20MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210826 002 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 40MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210826 003 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 80MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210826 004 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 120MG BASE No No 2023/01/06 2023/01/06 AUROBINDO PHARMA LTD Discontinued
LEVOMILNACIPRAN HYDROCHLORIDE 210771 001 ANDA LEVOMILNACIPRAN HYDROCHLORIDE CAPSULE, EXTENDED RELEASE;ORAL EQ 20MG BASE No No 2023/03/20 2023/03/20 PRINSTON INC Prescription
药品名称,活性成分,申请号搜索 高级检索
©2006-2024 DrugFuture->U.S. FDA Drugs Database